Publicaciones en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (17)

2023

  1. Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration

    Hepatology, Vol. 77, Núm. 4, pp. 1095-1105

2021

  1. Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study

    American Journal of Gastroenterology, Vol. 116, Núm. 11, pp. 2250-2257

2020

  1. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

    Antiviral Research, Vol. 174

  2. Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

    World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85

2019

  1. High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome

    Endoscopy, Vol. 51, Núm. 2, pp. 142-151

2018

  1. Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events

    Hepatology, Vol. 67, Núm. 2, pp. 612-622

  2. Effect of aspirin on the diagnostic accuracy of the faecal immunochemical test for colorectal advanced neoplasia

    United European Gastroenterology Journal, Vol. 6, Núm. 1, pp. 123-130

2017

  1. Relevance of DNA repair gene polymorphisms to gastric cancer risk and phenotype

    Oncotarget, Vol. 8, Núm. 22, pp. 35848-35862

  2. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients

    International Journal of Cancer, Vol. 140, Núm. 10, pp. 2201-2211

2016

  1. Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study

    Gut, Vol. 65, Núm. 11, pp. 1829-1837

  2. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

    BMC Medicine, Vol. 14, Núm. 1

2015

  1. Association of PSCA rs2294008 gene variants with poor prognosis and increased susceptibility to gastric cancer and decreased risk of duodenal ulcer disease

    International Journal of Cancer, Vol. 137, Núm. 6, pp. 1362-1373

  2. High efficacy and safety of triple therapy in hcv genotype 1 and moderate fibrosis: A multicenter study of clinical practice in Spain

    Annals of Hepatology, Vol. 14, Núm. 4, pp. 477-486

2012

  1. Prognostic Role of Host Cyclooxygenase and Cytokine Genotypes in a Caucasian Cohort of Patients with Gastric Adenocarcinoma

    PLoS ONE, Vol. 7, Núm. 9

  2. Relevance of GSTM1, GSTT1, and GSTP1 gene polymorphisms to gastric cancer susceptibility and phenotype

    Mutagenesis, Vol. 27, Núm. 6, pp. 771-777

2007

  1. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: A nationwide multicenter study in Spain

    American Journal of Gastroenterology, Vol. 102, Núm. 9, pp. 1878-1892

2004

  1. Genotipo y expresión fenotípica de la hemocromatosis hereditaria en España

    Gastroenterologia y Hepatologia, Vol. 27, Núm. 8, pp. 437-443